What MiDOG does

MiDOG Animal Diagnostics is a privately held veterinary diagnostics laboratory headquartered in Tustin, California, founded in 2019 and operating with 11–50 employees. The company provides culture-independent next-generation DNA sequencing (NGS) testing — using 16S rRNA and ITS amplicon sequencing plus Whole Genome Sequencing — to detect bacteria, fungi, parasites, antimicrobial resistance markers, biofilm genes, and toxin/virulence genes from a single animal sample in 2–3 business days. Its core product, the MiDOG All-in-One Microbial Test, is complemented by an Expanded Testing add-on (parasites, biofilm, toxin genes) and a recently launched WGS diagnostic service; the company also offers Research/Clinical Study support and Product Testing services for animal health manufacturers. Testing is supported by a proprietary bioinformatics pipeline, curated reference databases covering tens of thousands of species, and a DNA preservation reagent that stabilizes samples at room temperature for up to one year, eliminating cold-chain logistics.

The company sells primarily on a direct-to-veterinarian basis through a web portal, phone, and email ordering, with free collection kits billed only when samples are returned. Customers include small animal clinics, exotic and zoo animal hospitals, marine mammal rehabilitation centers, wildlife conservation programs, universities, and animal health product manufacturers; pet owners are reached indirectly through educational content that drives demand back to veterinarians. International access is provided via a Canadian distributor (BioVet) and ad hoc international arrangements. The revenue model is per-sample transaction-based for clinical testing, augmented by fee-for-service research and product testing engagements, with no subscriptions and no publicly disclosed pricing — prospective customers must contact MiDOG for current rates. Strategic positioning centers on scientific credibility (50+ peer-reviewed publications, a Scientific Advisory Board including Dr. Curtis Huttenhower, Dr. Micah Kohles, and Dr. Krista A. Keller) and a partnership with Hills Pet Nutrition linking diagnostics to therapeutic nutrition workflows.

Name

MiDOG

Legal name

MiDOG LLC

Website

https://midogtest.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

MiDOG Animal Diagnostics is a Tustin, California-based veterinary diagnostics laboratory that provides culture-independent next-generation DNA sequencing testing — bacteria, fungi, parasites, and antimicrobial resistance — for veterinarians treating companion animals, exotics, zoo species, and wildlife, with ancillary research and product testing services.

Ownership category

akta.pro rank

Product category

Veterinary Diagnostic Services

NAICS

Medical Laboratories (621511), Veterinary Services (541940)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC)

akta.pro secondary industries

Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA), Genomics & Next-Generation Sequencing (NGS) Services (HLAGANAA), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

Keywords

• Veterinary diagnostics
• Microbiome testing
• Next-generation sequencing
• Antimicrobial resistance profiling
• Animal pathogen detection

Headquarters

HQ city

Tustin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Per-Sample Diagnostic Testing: Veterinarians order free collection kits (swab, urine, or bulk kits) and pay a shipping fee when kits are shipped. They are only billed when samples are returned to the MiDOG laboratory for processing. Each kit contains 5 collection tubes and generates up to 5 separate test reports. This is a pay-per-sample model with no subscription required.
2. Whole Genome Sequencing (WGS) Diagnostic Service: Expanded comprehensive WGS testing service launched in California offering comprehensive microbial analysis including bacteria, fungi, parasites, AMR, and virulence factors from a single sample, billed as a premium diagnostic test.
3. Research and Clinical Study Services: MiDOG provides fee-for-service research support including study design, sample processing, sequencing, bioinformatics, statistical analysis, and publication support for academic institutions, veterinary teaching hospitals, DVM residents, and industry teams.
4. Product Testing Services: MiDOG supports product testing for pet food manufacturers, supplement developers, probiotic/prebiotic companies, veterinary therapeutics companies, and animal health product developers, providing microbiome analysis before, during, and after product use to evaluate product impact on animal microbiome composition.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels9 records

Core offering

MiDOG provides culture-independent, next-generation DNA sequencing (NGS) diagnostic testing services to veterinarians, detecting bacteria, fungi, parasites, antimicrobial resistance markers, biofilm genes, and toxin genes from a single animal sample in 2–5 business days. Veterinarians order free collection kits through the MiDOG portal or by phone/email, ship samples to the Tustin, California laboratory, and receive quantitative clinical reports with species-level identification plus free consultation support.

Product overview

MiDOG Animal Diagnostics offers a portfolio of veterinary diagnostic products centered on its All-in-One Microbial Test, which uses next-generation DNA sequencing to detect and quantify bacteria, fungi, and parasites from a single sample. The core All-in-One Test is complemented by Expanded Testing add-ons that include parasite detection, biofilm-associated markers, and toxin-associated markers. MiDOG provides specialized collection kits (swab, small-sized swab, urine, and bulk) for various sample types, and supports research and clinical studies through dedicated service offerings including study design guidance, bioinformatics, and publication support. The company also offers product testing services for pet food and supplement manufacturers, and residency project support for veterinary researchers.

Differentiator

Problem solved

Functional benefit

Brands

• MiDOG All-in-One Pet Microbiome Test: DNA-based diagnostic test powered by next-generation sequencing for comprehensive bacterial, fungal, parasitic, and AMR testing
• MiDOG Expanded Testing
• MiDOG Research Services

Products and services

• MiDOG All-in-One Microbial Test DNA-based next-generation sequencing diagnostic test for veterinary use that quantifies and identifies bacteria, fungi, and parasites from a single clinical sample with species-level resolution and antimicrobial resistance profiling; turnaround 2-3 business days. Available to veterinarians treating small animals, exotics, zoo, and marine/wildlife species.
• MiDOG Expanded Testing (Parasites, Biofilm, and Toxin Detection) Enhanced veterinary diagnostic testing service that adds parasite detection (protozoa, helminths, oomycetes), 92 biofilm-associated bacterial genes, and over 120 bacterial toxin/virulence gene families to the standard All-in-One Microbial Test, with profiling across 47 antibacterial and 9 antifungal drug options; designed for complex, culture-negative, polymicrobial, chronic, and treatment-resistant cases.
• Whole Genome Sequencing (WGS) Diagnostic Service Premium whole genome sequencing diagnostic service for animals launched in California, providing species-level identification and resistance profiling for bacteria, fungi, parasites, antimicrobial resistance markers, and virulence factors from a single sample with as little as 2-day turnaround.
• Research and Clinical Studies Support Fee-for-service research support including study design guidance, sample processing, next-generation sequencing, bioinformatics, data interpretation, statistical analysis, and publication support for academic veterinary microbiome research, infectious disease studies, antimicrobial resistance research, clinical case series, and intervention studies.
• Product Testing Services Microbiome-focused product testing service for pet food manufacturers, supplement developers, probiotic/prebiotic companies, and veterinary therapeutic product teams, providing before/during/after analysis of microbiome composition to evaluate product impact, support feeding trials, formulation comparisons, and evidence-based marketing.
• Residency Project Support Support service for veterinary residents completing research projects using MiDOG NGS technology, including study design assistance, sequencing, bioinformatics, and publication guidance.

Quantifiable outcome

• Detect up to 123,701 organisms including bacteria, fungi, protozoa, and parasites using NGS targeting 16S rRNA (bacteria) and ITS (fungi) regions
• +7 more outcomes

Named customers15 records

Segments6 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature8 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• Dr. Curtis Huttenhower (Scientific Advisory Board)coreOthers · 4 November 2025Appointed to MiDOG's Scientific Advisory Board in November 2025 to enhance next-generation microbiome diagnostics for animals. Dr. Huttenhower is a microbiome science expert who brings academic rigor and clinical insights to MiDOG's diagnostic development.
• Dr. Micah Kohles (Scientific Advisory Board)coreOthers · 4 November 2025Appointed to MiDOG's Scientific Advisory Board in November 2025 to enhance next-generation microbiome diagnostics for animals. Dr. Kohles contributes clinical veterinary expertise and microbiome science insights to guide MiDOG's diagnostic platform development.
• Dr. Krista A. Keller (Scientific Advisory Board)coreOthers · 4 November 2025Appointed to MiDOG's Scientific Advisory Board in November 2025 to enhance next-generation microbiome diagnostics for animals. Dr. Keller contributes zoo and exotic animal medicine expertise alongside microbiome science to broaden MiDOG's diagnostic applications across species.
• Hills Pet NutritioncoreStrategic or Co-development PartnerHills Pet Nutrition announced a partnership with MiDOG Animal Diagnostics. MiDOG's website features a 'NEW PARTNERSHIP ALERT' banner linking to a blog post about the Hills Pet Nutrition partnership, indicating a collaborative relationship focused on advancing pet microbiome health through partnership between advanced diagnostics and pet nutrition.
• Hill's Prescription DietminorStrategic or Co-development PartnerReferenced in Daisy the dog's case study as part of a urinary diet prescription (Hill's Prescription Diet c/d) used alongside MiDOG diagnostic testing for comprehensive urinary tract infection management. This represents a clinical co-management approach rather than a formal commercial partnership.
• BioVet (Canada)coreChannel Partner/ Reseller/ DistributorBioVet serves as the Canadian distributor for MiDOG Animal Diagnostics testing services. Canadian clients are directed to contact BioVet for assistance accessing MiDOG testing services, representing a formal international distribution arrangement for the Canadian market.
• Illumina (MiSeq Platform)coreTechnology or IntegrationMiDOG sequences samples on Illumina MiSeq platform. The company provides full-service sample processing including DNA/RNA extraction, library preparation, pooling and quality control, with positive and negative controls for all wet lab steps processed under standardized SOPs. Illumina sequencing technology is a core component of MiDOG's NGS service delivery.
• Pacific Marine Mammal Center (PMMC)minorStrategic or Co-development PartnerPMMC in Laguna Beach, CA is a nonprofit marine mammal rescue and rehabilitation organization that uses MiDOG's All-in-One Test to diagnose infectious diseases in stranded sea lions (e.g., the Hai-Xi case study). This collaboration demonstrates real-world clinical application of MiDOG technology in wildlife medicine.
• Saddleback Animal Hospital (Tustin, CA)minorStrategic or Co-development PartnerDr. Michael Kavanagh's Saddleback Animal Hospital has been a long-term collaborator with MiDOG, contributing multiple case studies (Daisy the dog's UTI, Heidi the dachshund's ear infection, Buddy the dog's diarrhea, the Tritrichomonas foetus case) and serving as a reference site for MiDOG technology validation.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• PetDx: PetDx offers liquid biopsy cancer detection for dogs using next-generation sequencing of cell-free DNA. While its focus is oncology rather than infectious disease, PetDx shares the veterinary NGS diagnostics category and a similar early-stage commercialization approach targeting veterinary specialists.
• Volition Veterinary: Volition Veterinary, a subsidiary of VolitionRx, develops Nu.Q Vet cancer screening tests for dogs and cats using nucleosome-based blood tests. While focused on oncology screening rather than infectious disease, Volition is a comparable emerging veterinary diagnostics company pursuing novel biomarker-driven testing for companion animals.
• Embark Veterinary: Embark offers direct-to-consumer genetic testing for dogs, including breed identification and disease risk screening. While Embark focuses on germline DNA rather than microbiome/infectious disease, it shares the pet-owner-facing genetic testing category and uses NGS technology, making it a partial technology and brand competitor.

Broad incumbents

• Antech Diagnostics (Mars Science & Diagnostics): Antech is one of the two largest veterinary reference lab networks in North America, owned by Mars Petcare. Antech is directly named in MiDOG customer testimonials as the prior lab veterinarians tried before adopting MiDOG, positioning it as the primary incumbent competitor on culture and infectious disease diagnostics.
• IDEXX Laboratories: IDEXX is the dominant veterinary diagnostics company globally, offering reference lab services, in-clinic analyzers, and a broad menu of tests. MiDOG competes with IDEXX on culture and infectious disease testing, and IDEXX's scale and hospital relationships represent the primary incumbent threat to MiDOG's NGS approach.
• Zoetis (Basepaws): Zoetis is the largest global animal health company and acquired Basepaws, a cat genetic testing company, in 2022. Zoetis has the distribution scale and R&D budget to bring genetic/microbiome diagnostics into mainstream veterinary practice, positioning it as a long-term competitive threat to MiDOG's specialty position.
• Eurofins Genomics: Eurofins Genomics is a global leader in commercial genomics and NGS services across multiple sectors including animal health and veterinary research. Eurofins has the lab infrastructure and scale to offer veterinary microbiome sequencing services that could compete with MiDOG's research and clinical study offerings.
• Heska (now part of Mars): Heska, acquired by Mars Petcare in 2023, provides in-clinic diagnostic instruments and reference lab services for veterinarians. Its integration with Antech under Mars Science & Diagnostics creates a combined competitive platform that overlaps with MiDOG across both in-clinic and reference lab diagnostics.

Direct peers

• AnimalBiome: AnimalBiome is the most direct competitor to MiDOG, offering microbiome-based diagnostic and therapeutic products for companion animals (dogs and cats). Both companies target veterinarians and pet owners with gut microbiome analysis using DNA sequencing, addressing similar use cases around chronic GI and skin conditions.

Others

• VetCheck (BioVet): BioVet is MiDOG's named Canadian distribution partner and a broader veterinary diagnostics distributor. As MiDOG's channel partner in Canada, BioVet is a relevant ecosystem participant rather than a direct competitor, but reflects the distribution model MiDOG relies on for international expansion.

Market position

Strengths5 records

Weaknesses3 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xlinkedin.com/company/midog
• YouTubeyoutube.com/channel/UCpY6-L33aGK1MpxhEGH37TA
• Facebookfacebook.com/midogtest
• LinkedInlinkedin.com/company/midog
• Instagraminstagram.com/midogtest

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MiDOG